Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole
Affiliations
Affiliations
- Department of Dermatology, Al-Sabah Hospital, Safat, Kuwait.
Abstract
Twenty-four patients suffering from single or multiple lesions of cutaneous leishmaniasis were included in this study. Most of the lesions were on the extremities. The patients were randomly divided into two groups. Most of the patients in the first group who were given oral itraconazole for a period of 6-8 weeks showed excellent clinical response. On the other hand, only one patient in the second control group who was given placebo showed good clinical improvement. Systemically administered itraconazole may prove to be a valuable modality for the treatment of cutaneous leishmaniasis.
Similar articles
Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.
Galvão EL, Rabello A, Cota GF.PLoS One. 2017 Oct 9;12(10):e0186117. doi: 10.1371/journal.pone.0186117. eCollection 2017.PMID: 29016694 Free PMC article. Review.
Ketoconazole in the treatment of cutaneous leishmaniasis in Kuwait.
Alsaleh QA, Dvorak R, Nanda A.Int J Dermatol. 1995 Jul;34(7):495-7. doi: 10.1111/j.1365-4362.1995.tb00622.x.PMID: 7591417 Clinical Trial. No abstract available.
Treatment of cutaneous leishmaniasis with itraconazole. Randomized double-blind study.
Momeni AZ, Jalayer T, Emamjomeh M, Bashardost N, Ghassemi RL, Meghdadi M, Javadi A, Aminjavaheri M.Arch Dermatol. 1996 Jul;132(7):784-6.PMID: 8678570 Clinical Trial.
El-Sayed M, Anwar AE.J Eur Acad Dermatol Venereol. 2010 Mar;24(3):335-40. doi: 10.1111/j.1468-3083.2009.03417.x. Epub 2009 Sep 10.PMID: 19744259 Clinical Trial.
Current therapies for treatment of cutaneous leishmaniasis in India.
Dogra J.Infection. 1992 Jul-Aug;20(4):189-91. doi: 10.1007/BF02033055.PMID: 1325946 Review. No abstract available.
Cited by
Cutaneous leishmaniasis: A neglected disfiguring disease for women.
Bilgic-Temel A, Murrell DF, Uzun S.Int J Womens Dermatol. 2019 Feb 10;5(3):158-165. doi: 10.1016/j.ijwd.2019.01.002. eCollection 2019 Jul.PMID: 31360749 Free PMC article.
Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Reveiz L, Garcia-Carrasco E, Campuzano Cuadrado P, Royuela A, Mendez Roman I, López-Vélez R.Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5.PMID: 29192424 Free PMC article. Review.
Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Reveiz L, Garcia-Carrasco E, Campuzano Cuadrado P, Royuela A, Mendez Roman I, López-Vélez R.Cochrane Database Syst Rev. 2017 Nov 17;11(11):CD005067. doi: 10.1002/14651858.CD005067.pub4.PMID: 29149474 Free PMC article. Updated. Review.
Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.
Galvão EL, Rabello A, Cota GF.PLoS One. 2017 Oct 9;12(10):e0186117. doi: 10.1371/journal.pone.0186117. eCollection 2017.PMID: 29016694 Free PMC article. Review.
Cutaneous Leishmaniasis in a Nonendemic Area of South Rajasthan: A Prospective Study.
Balai M, Gupta LK, Khare AK, Srivastava A, Mittal A, Singh A.Indian J Dermatol. 2016 Sep-Oct;61(5):521-4. doi: 10.4103/0019-5154.190117.PMID: 27688441 Free PMC article.